Skip to main content
OpenTrials
Completed

NCT Number: NCT02934737

Role of markErs in the progreSsion of dIabeteS in Obese paTIeNts

Obese patients will be enrolled from 2006 to 2014. The progression of diabetes mellitus will be observed (if any). Anthropometric and biochemical parameters will be evaluated.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obese Patients Body Weight Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Obesity (body mass index >/= 30 Kg/m2
  • Normal blood glucose (glycemia < 100 mg/dl)

Exclusion criteria

  • No exclusion criteria

Treatment and study plan

Progression of diabetes

Other

Other names: Variations of biochemical parameters

Primary outcomes

  1. Progression of diabetes

    Time frame: 8 years

    evaluation of glycemia during 8 years

  2. Anthropometric parameters

    Time frame: 8 years

    Weight

  3. Anthropometric parameters

    Time frame: 8 years

    Waist circumference; hip circumference; abdominal circumference

  4. Markers of progression of diabetes

    Time frame: 8 years

    Adiponectin

  5. Markers of progression of diabetes

    Time frame: 8 years

    Resistin

Sponsors and collaborators

Lead sponsor

University of Pavia

Other

Registry information

Official study title

Role of Some Markers in the Progression of Diabetes in Obese Patients: a 8-year Observational Study

Acronym: RESISTIN

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Oct 17, 2016
Registry last updated
Nov 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.